Doctors test Direct-to-Chest immune cell therapy for tough lung cancers

NCT ID NCT07116057

Summary

This is an early safety study testing a new type of personalized immune cell therapy for people with advanced non-small cell lung cancer that has spread to the lining of the chest. Doctors will collect a patient's own immune cells, modify them in a lab to target a specific protein found on some cancer cells, and then infuse them directly into the chest cavity. The main goals are to see if this approach is safe and feasible, and to get an early look at whether it might help control the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT LUNG NON-SMALL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.